Ophthalmic formulations new goals
Fernández-Ferreiro A, González-Barcia M, Otero Espinar FJ, Blanco Méndez J, Lamas MJ.Farm Hosp. 2016 Jan 1;40(1):1-2. doi: 10.7399/fh.2016.40.1.10417.PMID: 26882828
Categoría: Galeno 4.0
Ocular safety comparison of non-steroidal anti-inflammatory eye drops used in pseudophakic cystoid macular edema prevention.
Fernández-Ferreiro A, Santiago-Varela M, Gil-Martínez M, Parada TG, Pardo M, González-Barcia M, Piñeiro-Ces A, Rodríguez-Ares MT, Blanco-Mendez J, Lamas MJ, Otero-Espinar FJ.Int J Pharm. 2015 Nov 30;495(2):680-91. doi: 10.1016/j.ijpharm.2015.09.058. Epub 2015 Sep 28.PMID: 26423177
Chitosan and Kappa-Carrageenan Vaginal Acyclovir Formulations for Prevention of Genital Herpes. In Vitro and Ex Vivo Evaluation.
Sánchez-Sánchez MP, Martín-Illana A, Ruiz-Caro R, Bermejo P, Abad MJ, Carro R, Bedoya LM, Tamayo A, Rubio J, Fernández-Ferreiro A, Otero-Espinar F, Veiga MD.Mar Drugs. 2015 Sep 18;13(9):5976-92. doi: 10.3390/md13095976.PMID: 26393621
In vitro and in vivo ocular safety and eye surface permanence determination by direct and Magnetic Resonance Imaging of ion-sensitive hydrogels based on gellan gum and kappa-carrageenan.
Fernández-Ferreiro A, González Barcia M, Gil-Martínez M, Vieites-Prado A, Lema I, Argibay B, Blanco Méndez J, Lamas MJ, Otero-Espinar FJ.Eur J Pharm Biopharm. 2015 Aug;94:342-51. doi: 10.1016/j.ejpb.2015.06.003. Epub 2015 Jun 14.PMID: 26079831
Cyclodextrin-polysaccharide-based, in situ-gelled system for ocular antifungal delivery.
Fernández-Ferreiro A, Fernández Bargiela N, Varela MS, Martínez MG, Pardo M, Piñeiro Ces A, Méndez JB, Barcia MG, Lamas MJ, Otero-Espinar F.Beilstein J Org Chem. 2014 Dec 8;10:2903-11. doi: 10.3762/bjoc.10.308. eCollection 2014.PMID: 25550757
Analysis of ocular toxicity of fluconazole and voriconazole eyedrops using HET-CAM
Fernández-Ferreiro A, González Barcia M, Gil Martínez M, Blanco Mendez J, Lamas Díaz MJ, Otero Espinar FJ.Farm Hosp. 2014 Jul 1;38(4):300-4. doi: 10.7399/fh.2014.38.4.7343.PMID: 25137163
